Heart Beat: Gains for new heart disease marker
Heart Beat
Gains for new heart disease marker
C-reactive protein (CRP), one of the newest villains in heart disease, may be inching closer to joining high cholesterol as a cause of this all-too-common malady.
In two separate studies of people at very high risk for heart attack and stroke, cholesterol-lowering statin therapy proved more effective at preventing heart attacks or halting the progression of artery-clogging plaque when CRP levels fell along with cholesterol. These results, which were published in the January 6, 2005, New England Journal of Medicine, suggest that CRP may be more than just an innocent bystander, and that it may actually play a role in heart disease.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.